NEWS DETAIL

FDA phê duyệt liệu pháp mới sử dụng tế bào miễn dịch từ người hiến tặng để ngăn ngừa các biến chứng nghiêm trọng ở bệnh nhân mắc bệnh ung thư máu.

Đuôi trang web .gov cho biết đây là trang web chính thức.

Thông tin y tế

Noi dung day du cua bai viet

Food and Drug Administration today approved TREGZI, the first regulatory T (Treg) cell-based immunotherapy for improving chronic graft-versus-host disease (GVHD)-free survival in adult patients with blood cancers undergoing allogeneic hematopoietic stem cell transplantation (allo-HSCT).

Câu hỏi thường gặp

Which products are related to this article?

No strongly related product has been identified yet. The match updates automatically when the article or catalog changes.

How can I view the medicines discussed in this article?

Use the related product cards below the article to review available specifications, prices, product information, and reviews.

Does this article replace advice from a doctor or pharmacist?

No. This content is for general information and health education only. Follow the prescription and individual guidance provided by qualified healthcare professionals.

WhatsApp WhatsApp WeChat WeChat